Kelly Lawrence W & Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Kelly Lawrence W & Associates's ADNT Position: Q1 2025 in Review
Kelly Lawrence W & Associates sold out of Adient (ADNT) in Q1 2025, closing a stake of 2 shares — an estimated $34 sold.
Kelly Lawrence W & Associates first reported a position in ADNT in Q2 2022 and held it in 11 quarters. The position peaked at $82 in Q1 2023. 269 funds tracked by Wall St. Rank hold ADNT as of Q1 2025.
- Kelly Lawrence W & Associates reported no remaining Adient position as of Q1 2025 after selling out during the quarter.
- Kelly Lawrence W & Associates sold 2 Adient shares in Q1 2025, an estimated $34.
- Kelly Lawrence W & Associates first reported a position in Adient in Q2 2022 and held it in 11 quarters.
- Kelly Lawrence W & Associates's Adient position peaked at $82 in Q1 2023.
- 269 funds tracked by Wall St. Rank held Adient as of Q1 2025.
Based on Kelly Lawrence W & Associates's 13F filing for Q1 2025, filed 14 May 2025.